A Study to Evaluate the Safety and Immunogenicity of the V3-region Directed Immunogens DV700P-RNA Followed by DV701B1.1-RNA in Adults Without HIV
Clinical trial NCT06919016 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06919016
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-06
- Primary completion
- 2027-03-25
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.